share_log

Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $28 Price Target

Moomoo 24/7 ·  Mar 21 08:47

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment